Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-Month, Randomized, Double-Masked, Placebo-Controlled Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

NCT07290530 is registered in ClinicalTrials.gov with Nacuity Pharmaceuticals, Inc. as lead sponsor.

NCT NCT07290530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-Month, Randomized, Double-Masked, Placebo-Controlled Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
Lead sponsor
Nacuity Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
July 31, 2029
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa (rp), usher syndrome